DNMT3A and leukemia: Consistently, the regioisomers 2a–c and 4b,c, which were more potent than the prototypes 2 and 4 against DNMT3A, showed antiproliferative effects at submicromolar or single-digit micromolar levels against both the tested leukemia cell lines.